The 20 Best Atypical Teratoid Rhabdoid Tumor (ATRT) Doctors Near Me in Ann Arbor, MI

Dr. Leung is the Director of the Neuro-Oncology Fellowship Program and is a clinical assistant professor in the Department of Neurology. She sees patients in the Neuro-Oncology Clinic at the Rogel Cancer Center and at the Northville Health Center. She completed a bachelor’s degree at the University of Western Ontario, a master’s degree at the University of Toronto, and medical degree at SUNY Upstate. Dr. Leung completed her Neurology residency and Neuro-Oncology fellowship at Henry Ford Hospital. Dr. Leung is rated as a Distinguished provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Metastatic Brain Tumor. Dr. Leung is board certified in Neurology.

Dr. Wajd Al-Holou was raised in southeast Michigan. After attending the University of Michigan Medical School, where he graduated with the highest award for research, he then began a 7-year Neurosurgery residency at the University of Michigan. Upon completion of residency in 2016, he completed a Complex Neurosurgical Oncology Fellowship at the MD Anderson Cancer Center in Houston, TX. His training focused on the management of complex brain tumors, spinal tumors, and skull base malignancies.Dr. Al-Holou specializes in the management of complex brain tumors, primarily focusing on gliomas and metastases to the brain. Dr. Al-Holou has expertise in the use of awake mapping techniques, microsurgery, and image-guidance to maximize tumor removal in the safest possible manner. He also specializes in the management of meningiomas and spinal tumors.Dr. Al-Holou is the co-founder and co-director of the Michigan Medicine Multidisciplinary Brain Tumor Clinic (M3BTC). As a member of this Neuro-Oncology multidisciplinary team, he works strategically to ensure personalized treatment recommendations that will maximize the benefits for each individual patient.Currently, he is a member of the AANS/CNS Executive Committee of the Section on Tumors. He served as the Co-Chair for Tumor Section Scientific Program for the American Association of Neurological Surgeons (AANS) in 2018 and is a member of the Society of Neuro-Oncology. He also serves as an editor for cancer journal, BMC Cancer.Dr. Al-Holou is committed to research and education in Neurosurgery and his life-long goal is improving the survival and outcomes for patients with tumors. His research interest focuses primarily on understanding the genetic mechanisms of recurrence in glioblastoma, and in identifying precision medicine therapies to target resistant tumors. Dr. Al is rated as a Distinguished provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Astrocytoma, Oligodendroglioma, and Awake Craniotomy. Dr. Al is board certified in Neurological Surgery.

Dr. Wahl is a physician scientist at the University of Michigan specializing in cancers of the central nervous system. His research focuses on the development of new treatment strategies for brain tumors and his laboratory group is especially interested in interactions between radiation and abnormal metabolism in glioblastoma. In the clinic, he cares for a wide variety of patients with both malignant and benign tumors of the central nervous system. Dr. Wahl is rated as a Distinguished provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Dr. Jason Heth attended The University of Iowa where he received his medical degree and also completed his residency in Neurosurgery. Dr. Heth then completed additional training in Skull Base Neurosurgery, completing a fellowship at the University of Arkansas for Medical Sciences. After completing his fellowship, he joined the faculty of the University of Michigan. Dr. Heth specializes in brain tumor treatment, including surgical removal, radiosurgery, and basic research. His primary areas of interest focus on gliomas, glioblastoma, brain metastasis, and meningiomas. He is also involved in medical student education and quality improvement programs at the University of Michigan. Dr. Heth is rated as a Distinguished provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Brain Tumor, Awake Craniotomy, and Gastrostomy. Dr. Heth is board certified in Neurological Surgery.

Michelle Kim, M.D. is an associate professor in the Department of Radiation Oncology at the University of Michigan. She completed her medical training at Case Western Reserve University and her residency at MD Anderson Cancer Center. Dr. Kim is board-certified in Radiation Oncology by the American Board of Radiology. Her research focus is in the adaptive individualization of radiation therapy using advanced molecular and functional imaging for patients with central nervous system tumors including gliomas and brain metastases. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Metastatic Brain Tumor, and Astrocytoma. Dr. Kim is board certified in Radiation Oncology.

Larry Junck is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Junck is rated as a Distinguished provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Brain Tumor.

Dr. Mihaylova was born and raised in Bulgaria where she completed Medical School at the University of Sofia in 1997. Subsequently she extended her training into a three-year post-doctoral program and conducted clinical research on newly diagnosed epilepsy patients. She was granted her PhD degree in 2002. Since then she has been living in the US where she completed her Neurology residency at Wayne State University followed by a year of fellowship training in Clinical Neurophysiology with emphasis on Epilepsy/EEG at the same institution. Her primary clinical and research interests involve the treatment of medically intractable epilepsy including VNS and surgical treatment, EEG analysis and seizure semiology. Dr. Mihaylova is rated as an Experienced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Seizures, Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE), Generalized Tonic-Clonic Seizure, and Partial Seizure. Dr. Mihaylova is board certified in Neurology, Clinical Neurophysiology, and Epilepsy.

Dr. Derek Bergsma is active in clinical practice at the Lacks Cancer Center Department of Radiation Oncology in Grand Rapids. He received his undergraduate degree from Grand Valley State University and then worked in cancer immunodiagnostics at Van Andel Institute before obtaining his medical degree from Michigan State University College of Human Medicine. He completed both internship and Radiation Oncology residency at the University of Rochester in Rochester, NY. Dr. Bergsma is rated as an Advanced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Brain Tumor, Astrocytoma, and Oligodendroglioma. Dr. Bergsma is board certified in Radiation Oncology.

Dr. Patricia Robertson, M.D., earned a medical degree at Wayne State University Medical School in Detroit and completed a residency in pediatrics at Children's Hospital of Michigan. She then went on to a fellowship in pediatric neurology at the University of Michigan and trained in pediatric neuro-oncology at New York University Medical Center. Dr. Robertson joined the University of Michigan faculty in 1988. She has a special interest in clinical pediatric neuro-oncology focusing on the evaluation of response, outcome and late effects on the developing nervous system; current treatment strategies for children with central nervous malignancies; and in the development of innovative treatment approaches for this population. Dr. Robertson is rated as an Advanced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). She is also highly rated in 42 other conditions, according to our data. Her clinical expertise encompasses Glioma, Diencephalic Syndrome, Brain Stem Cancer, and Brain Tumor.

Hugh Garton is a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. Dr. Garton is rated as an Advanced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). He is also highly rated in 72 other conditions, according to our data. His clinical expertise encompasses Chiari Malformation, Chiari Malformation Type 1, Chiari Malformation Type 2, Posterior Fossa Decompression, and Gamma Knife Radiosurgery. Dr. Garton is board certified in Neurological Surgery.

Nathan Clarke is a Neurologist practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 10 years. Dr. Clarke is rated as an Advanced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Brain Tumor, and Glioblastoma. Dr. Clarke is board certified in Neurology.

Dr. Lawrence structured his career to prepare to be a physician scientist by obtaining both an MD and PhD. He initially pursued internal medicine and medical oncology, but ultimately settled on radiation oncology. He is board certified in all 3 areas. He has had an active clinical practice in radiation oncology for 30 years specializing in the treatment of patients with gastrointestinal malignancies and CNS tumors.Dr. Lawrence has focused his research career in two main areas. First, in collaboration with basic scientists he developed a laboratory program in chemotherapeutic radiation sensitizers and, more recently, has studied how to integrate molecularly targeted therapies. He collaborates with basic science faculty interested in translational research to investigate new combinations that can form the basis for rational clinical trials. The second area of focus involves the use of highly conformal radiation therapy in the treatment of brain and gastrointestinal cancers. In particular, he is focusing, in collaboration with medical physicists, radiologists, imaging scientists, and biologists, on the concept of adapting treatment to the individual patient response, assessed both by state-of-the-art imaging and plasma biomarkers.Dr. Lawrence is the author of over 300 peer-reviewed publications, and his work has been continuously supported by the National Cancer Institute for over 20 years. Dr. Lawrence is rated as an Advanced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Glioma, Glioblastoma, Astrocytoma, Pancreaticoduodenectomy, and Tissue Biopsy. Dr. Lawrence is board certified in Radiation Oncology, Medical Oncology, and Internal Medicine.

After completing his chief residency at the University of Virginia, Dr. Sagher accepted a position on the neurosurgical faculty at the University of Michigan. He became Chief of Neurosurgery at the Ann Arbor Veterans Administration Hospital, a position he held until 1996. He then completed a fellowship in Pain and Functional Neurosurgery at the Oregon Health Sciences University, and took over as the Director of Neuromodulation at the University of Michigan. As the primary functional neurosurgeon at the University of Michigan, Dr. Sagher takes care of such problems as epilepsy, pain, Parkinson's Disease and other movement disorders. Dr. Sagher is board certified by the American Board of Neurological Surgeons, and is a member of the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS). He has served on the Executive Council on the AANS/CNS Joint Section on Pain, which he chaired from 2003 to 2005. Special Interests: The treatment of epilepsy, pain, movement disorders, and brain tumors in functionally important regions. Dr. Sagher is rated as an Advanced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Trigeminal Neuralgia, Meningioma, Seizures, Awake Craniotomy, and Microvascular Decompression. Dr. Sagher is board certified in Neurological Surgery.

David Altshuler is a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. Dr. Altshuler is rated as an Advanced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Pituitary Tumor, Rathke Cleft Cyst, Craniopharyngioma, Awake Craniotomy, and Extracranial-Intracranial Bypass Surgery.

Wayne Cornblath is a Neurologist and an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Cornblath is rated as an Experienced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Optic Neuritis, Myasthenia Gravis, Increased Intracranial Pressure, and Benign Essential Blepharospasm.

From 2013 to 2015 Dr. De Lott studied for and obtained an MS, Health and Healthcare Research at the University of Michigan, Rackham Graduate School in Ann Arbor, Michigan. Dr. Delott is rated as an Experienced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Optic Neuritis, Papilledema, Pseudotumor Cerebri Syndrome, and Increased Intracranial Pressure. Dr. Delott is board certified in Neurology.

Mollie McDermott, MD, MS, is an assistant professor in the Department of Neurology. She completed subspecialty training in Vascular Neurology. She received her bachelor’s degree from Mount Holyoke College and her medical degree from Dartmouth Medical School. Dr. McDermott completed her residency training in Neurology at the University of Michigan, where she served as chief resident from 2014 to 2015. In 2017 she received her master of science degree in clinical research design and statistical analysis from the University of Michigan.Dr. McDermott is interested in acute stroke management, secondary stroke prevention, cardioembolic stroke, and atypical causes of stroke. She is the director of the Telestroke Program and the medical director of the Comprehensive Stroke Center. Dr. Mcdermott is rated as an Experienced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Stroke, Dysarthria, Cerebral Amyloid Angiopathy, Stent Placement, and Transmyocardial Revascularization. Dr. Mcdermott is board certified in Neurology and Vascular Neurology.

Michael M. Wang, M.D. Ph.D., is an assistant professor of neurology and director of molecular stroke research in the Department of Neurology at the University of Michigan. He also is an assistant professor of molecular and integrative physiology at the U-M and a physician in neurology at the VA Ann Arbor Healthcare System.Dr. Wang's research includes laboratory investigations into the molecular basis of stroke and the interaction between stroke, circadian rhythms and disordered sleep. A major interest of the lab is investigating the causes and treatment of CADASIL (Cerebral Autosomal Dominant Arteriopathy Subcortical Infarcts and Leukoencephalopathy), a devastating inherited cause of stroke and vascular dementia. His other interests include studies of the functions of endogenous hormones (estrogen) and differentiation factors on neurons.He received his bachelor's degree, summa cum laude, from Harvard University and earned his medical degree and doctorate in molecular biology and genetics from Johns Hopkins University (JHU) in 1994. In 1998, he completed his neurology residency at JHU; in 2000, he completed a stroke research fellowship with Drs. Richard Traystman and Patricia Hurn. Dr. Wang spent three years on the neurology faculty at JHU before joining the U-M faculty in 2003. During his time at JHU, he also served as a staff neurologist at the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center, both in Baltimore, Maryland.Dr. Wang was elected to Phi Beta Kappa during his junior year at Harvard and to Alpha Omega Alpha at JHU. While a fellow, he was awarded funding from the National Stroke Association and the American Heart Association, and also received a Burroughs Wellcome Career Award in Biomedical Sciences. His research has been supported by the National Institutes of Health (NIH) since 2001.He has published his scientific work in Nature, Journal of Neuroscience and Stroke, and has served as a member of national grant review committees of the NIH and the American Heart Association. His bibliography includes more than 20 peer-reviewed publications, seven book chapters, and numerous abstracts and clinical papers. He also is an ad hoc reviewer for the Journal of Cerebral Blood Flow and Metabolism, American Journal of Physiology, Stroke, and Neurology, among others.At the U-M, Dr. Wang is involved in medical student pre-clinical education, resident education and clinical studies conducted by the U-M Brain Injury Group. He is a member of the Stroke Council of the American Heart Association and a member of the Society of Neuroscience. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, Vascular Dementia, Stroke, Stent Placement, and Transmyocardial Revascularization. Dr. Wang is board certified in Vascular Neurology and Neurology.

Garrett Conyers graduated Phi Beta Kappa and with honors from Morehouse College. He received his MD from Harvard Medical School during which time he also completed a Masters in Public Policy from the Harvard Kennedy School of Government. He took two years off in medical school to lead a community participatory research project looking into health inequities in underserved communities in Boston. Dr. Conyers then completed a neurology residency at the Johns Hopkins Hospital followed by a fellowship in vascular neurology at the University of Michigan. Clinically, he has a special interest in moyamoya disease and shared decision making. He is involved in several diversity, equity and inclusion committees nationally. He is passionate about healthcare equity and optimizing systems of care for vulnerable populations, such as imprisoned and socioeconomically disadvantages patients. Dr. Conyers is rated as an Experienced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Stroke, Moyamoya Disease, Dysarthria, Thrombectomy, and Transmyocardial Revascularization. Dr. Conyers is board certified in Neurology.

Darin B. Zahuranec, M.D. (Residency 2005), is a professor of neurology in the University of Michigan Medical School. He joined the U-M faculty in 2005 as a clinical lecturer in the Department of Neurology, and was promoted to professor of neurology in 2007.Dr. Zahuranec received his bachelor's degree, summa cum laude, from Case Western Reserve University in Cleveland, Ohio, in 1997, and earned his medical degree from Case Western Reserve in 2001. He completed an internship at University Hospitals of Cleveland; residency in the Department of Neurology at the U-M, where he served as chief resident in 2004-05; and a fellowship in stroke and cerebrovascular disease here.In addition to his U-M appointments, Dr. Zahuranec also has served as a staff physician in the Department of Neurology at the VA Ann Arbor Healthcare System and a research staff physician in emergency medicine at Saint Joseph Mercy Hospital in Ann Arbor.His current research activities include, Pilot Study of Gated Cardiac Magnetic Resonance Imaging for Detection of Embolic Source after Ischemic Stroke, Brain Atrophy in Intracerebral Hemorrhage Patients, Brain Attack Surveillance in Corpus Christi (BASIC), Carotid Occlusion Surgery Study (COSS), and Randomized Evaluation of Recurrent Stroke Comparing Patent Foramen Ovale Closure to Established Current Standard of Care Treatment (RESPECT).Dr. Zahuranec has served as an ad hoc reviewer for Neurology, the New England Journal of Medicine and the Journal of Neuroophthalmology, and currently reviews for Stroke. He is a member of the Stroke Council of the American Heart Association, the American Academy of Neurology and the American Medical Association.His bibliography includes numerous peer-reviewed publications, book chapters, abstracts and clinical papers. Dr. Zahuranec is rated as an Experienced provider by MediFind in the treatment of Atypical Teratoid Rhabdoid Tumor (ATRT). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Stroke, Transient Ischemic Attack (TIA), Moyamoya Disease, Thrombectomy, and Stent Placement. Dr. Zahuranec is board certified in Vascular Neurology and Neurology.